Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
filingDate |
2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ef9cd88096898ab93debbea10e1ee7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_166c311f51aef33b65e05b78a9969b4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edd6e5b53a94a5e8bd26ee72e7a01cb1 |
publicationDate |
2011-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011001267-A |
titleOfInvention |
Colorectal cancer treatment |
abstract |
A novel method for treating colorectal cancer is provided. A therapeutic agent for colorectal cancer comprising siRNA of AMIGO2 gene or anti-AMIGO2 antibody or antibody fragment thereof. That is, short interfering RNA (hereinafter referred to as siRNA) is a transcription product (mRNA) of the AMIGO2 gene and complementary to the target sequence (antisense RNA strand) and RNA complementary to the RNA ( Sense RNA strand) is a double-stranded RNA, and when siRNA is introduced into a cell, an RNAi phenomenon occurs and RNA having a homologous sequence is degraded, but siRNA of the present invention is mRNA of AMIGO2 gene Can be specifically targeted to suppress the expression of AMIGO2 involved in colorectal cancer. [Selection figure] None |
priorityDate |
2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |